BlackRock Health Sciences Term Trust (BMEZ) To Go Ex-Dividend on May 14th

BlackRock Health Sciences Term Trust (NYSE:BMEZ) announced a monthly dividend on Wednesday, May 1st, Zacks reports. Stockholders of record on Wednesday, May 15th will be given a dividend of 0.09 per share on Friday, May 31st. This represents a $1.08 annualized dividend and a dividend yield of 7.15%. The ex-dividend date is Tuesday, May 14th.

BlackRock Health Sciences Term Trust has increased its dividend payment by an average of 16.5% per year over the last three years.

BlackRock Health Sciences Term Trust Stock Up 1.8 %

Shares of BlackRock Health Sciences Term Trust stock traded up 0.26 during trading on Friday, hitting 15.10. 160,200 shares of the stock were exchanged, compared to its average volume of 322,110. BlackRock Health Sciences Term Trust has a 1-year low of 12.93 and a 1-year high of 16.59. The company has a fifty day moving average price of 15.74 and a 200-day moving average price of 14.95.

Insider Activity

In other news, major shareholder Saba Capital Management, L.P. bought 93,967 shares of the company’s stock in a transaction on Monday, February 5th. The stock was purchased at an average cost of 15.56 per share, for a total transaction of 1,462,126.52. Following the completion of the transaction, the insider now owns 18,690,059 shares of the company’s stock, valued at 290,817,318.04. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Over the last 90 days, insiders acquired 1,142,444 shares of company stock valued at $18,333,831.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.